EUVIMEDEUVIMED entdecken
Crossref

Atraric acid attenuates chronic intermittent hypoxia-induced brain injury via AMPK-mediated Nrf2 and FoxO3a antioxidant pathway activation

Mengxin Li, Jun Wang, Zihan Xu, Yue Lin, Jingquan Dong

Phytomedicine · 2025-11 · 148 · 157261

DOI: 10.1016/j.phymed.2025.157261 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2025-11. Verfasst von Mengxin Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Marine Pharmaceutical Resources Development Engineering Research Center, Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, …. Hauptthemen laut MEDLINE: Neuroprotective Agents, Forkhead Box Protein O3, Hypoxia, Brain Injuries. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions, Nanjing Medical University, Priority Academic Program Development of Jiangsu Higher Education Institutions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Obstructive sleep apnea syndrome (OSAS), a chronic disorder affecting approximately 10 % of adults worldwide with heightened prevalence in males and obese populations, induces irreversible neurocognitive impairment. Atraric Acid (AA), a natural depside compound derived from lichens, exhibits dual functional properties through its molecular groups capable of free radical scavenging and metal chelation. However, its therapeutic potential in OSAS-related pathologies remains unexplored. OBJECTIVE: This study aims to investigate the neuroprotective effects and molecular mechanisms of AA against CIH-induced neuronal damage. METHODS: CIH mouse models and hypoxic injury models in HT22 neurons were established. AA was administered to mice at doses of 5, 10, and 20 mg/kg (selected based on literature references and preliminary experiments), and to cells at an optimal concentration of 20 μM (determined by CCK-8 assays). Therapeutic efficacy was evaluated through behavioral tests including the Morris Water Maze, Elevated Plus Maze, and Open Field Test. Neuroprotective effects were assessed via histopathological examination (e.g., neuronal survival in hippocampal CA3 and DG sub-regions) and detection of oxidative stress/ferroptosis markers (e.g., MDA levels, GPX4 expression, and related biomarkers). Transcriptomic sequencing and molecular docking analyses were employed to investigate differentially expressed genes, pathway enrichment, and underlying mechanisms. RESULTS: In vivo and in vitro experiments demonstrated that AA significantly alleviated neuronal damage in CIH mice and enhanced HT22 cell viability. AA down-regulated oxidative stress- and ferroptosis-related gene expression. Transcriptomic sequencing identified AMPK signaling as a key target. Combined AMPK inhibitor (Compound C) and nuclear-cytoplasmic fractionation experiments confirmed that AA synergistically regulates dual antioxidant pathways (Nrf2/HO-1 and FoxO3a/SOD2) via AMPK activation. CONCLUSION: AA mitigates CIH-induced neurocognitive impairment by AMPK-dependent activation of the Nrf2/HO-1 and FoxO3a/SOD2 axes, establishing a dual antioxidant-ferroptosis defense barrier. This study is the first to systematically elucidate AA's molecular mechanisms using transcriptomics data integrated with computational simulations, providing novel therapeutic targets and a translational paradigm for developing natural compound-based therapies for OSAS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroprotective AgentsForkhead Box Protein O3HypoxiaBrain InjuriesAnimalsMiceNF-E2-Related Factor 2MaleAMP-Activated Protein KinasesAntioxidantsSignal TransductionCell LineDisease Models, AnimalOxidative StressSleep Apnea, ObstructiveNeuronsMice, Inbred C57BL

Stichwörter der Autor:innen

AMPKAtraric acidChronic intermittent hypoxiaNeuronal injuryOxidative stress

Substanzen

NF-E2-Related Factor 2Neuroprotective AgentsForkhead Box Protein O3AMP-Activated Protein KinasesNfe2l2 protein, mouseAntioxidantsFoxO3 protein, mouse

Autor:innen und Institutionen

  • Jiangsu Marine Pharmaceutical Resources Development Engineering Research Center, Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, College of Pharmacy, Jiangsu Ocean University, Lianyungang 222005, Chi…

Förderung

  • Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions
  • Nanjing Medical University
  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • Graduate Research and Innovation Projects of Jiangsu Province

Zitieren

APA

Li, M., Wang, J., Xu, Z., Lin, Y., & Dong, J. (2025). Atraric acid attenuates chronic intermittent hypoxia-induced brain injury via AMPK-mediated Nrf2 and FoxO3a antioxidant pathway activation. Phytomedicine, 148, 157261. https://doi.org/10.1016/j.phymed.2025.157261

Vancouver

Li M, Wang J, Xu Z, Lin Y, Dong J. Atraric acid attenuates chronic intermittent hypoxia-induced brain injury via AMPK-mediated Nrf2 and FoxO3a antioxidant pathway activation. Phytomedicine. 2025;148:157261. doi:10.1016/j.phymed.2025.157261

BibTeX
@article{Li2025,
  author = {Li, Mengxin and Wang, Jun and Xu, Zihan and Lin, Yue and Dong, Jingquan},
  title = {Atraric acid attenuates chronic intermittent hypoxia-induced brain injury via AMPK-mediated Nrf2 and FoxO3a antioxidant pathway activation},
  journal = {Phytomedicine},
  year = {2025},
  volume = {148},
  pages = {157261},
  doi = {10.1016/j.phymed.2025.157261}
}
Kostenlos starten →